Home > Balance Sheet > NEULAND LABORATORIES

NEULAND LABORATORIES
Contingent Liabilities

    Back to Balance Sheet
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹8.97 Cr₹28 Cr₹91 Cr₹75 Cr₹105 Cr

What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?

The latest Contingent Liabilities ratio of NEULAND LABORATORIES is ₹8.97 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹8.97 Cr
Mar2024₹28 Cr
Mar2023₹91 Cr
Mar2022₹75 Cr
Mar2021₹105 Cr

How is Contingent Liabilities of NEULAND LABORATORIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹8.97 Cr
-67.65
Mar2024 ₹28 Cr
-69.60
Mar2023 ₹91 Cr
22.14
Mar2022 ₹75 Cr
-28.68
Mar2021 ₹105 Cr -

Compare Contingent Liabilities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,830.4 Cr 4.2% -6% -8.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

4.2%

-6%

-8.2%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses